Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study
在一项单臂、多中心、开放标签的 II 期研究中,评估 orelabrutinib 单药治疗复发或难治性华氏巨球蛋白血症患者的疗效
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101682
Cao, Xin-Xin; Jin, Jie; Fu, Cheng-Cheng; Yi, Shu-Hua; Zhao, Wei-Li; Sun, Zi-Min; Yang, Wei; Li, Deng-Ju; Cui, Guo-Hui; Hu, Jian-da; Liu, Ting; Song, Yong-Ping; Xu, Bing; Zhu, Zun-Min; Xu, Wei; Zhang, Ming-Zhi; Tian, Ya-Min; Zhang, Bin; Zhao, Ren-Bin; Zhou, Dao-Bin